Shanghai Runda Medical Technology Co Ltd
SSE:603108

Watchlist Manager
Shanghai Runda Medical Technology Co Ltd Logo
Shanghai Runda Medical Technology Co Ltd
SSE:603108
Watchlist
Price: 17.31 CNY -0.46%
Market Cap: 10.4B CNY
Have any thoughts about
Shanghai Runda Medical Technology Co Ltd?
Write Note

Gross Margin
Shanghai Runda Medical Technology Co Ltd

25.9%
Current
27%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
25.9%
=
Gross Profit
2.2B
/
Revenue
8.4B

Gross Margin Across Competitors

Country CN
Market Cap 10.4B CNY
Gross Margin
26%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 202.3B USD
Gross Margin
41%
Country US
Market Cap 166.6B USD
Gross Margin
60%
Country KR
Market Cap 67T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.8B USD
Gross Margin
55%
Country US
Market Cap 36.3B USD
Gross Margin
35%
Country US
Market Cap 27B USD
Gross Margin
59%
Country US
Market Cap 24.1B USD
Gross Margin
35%
Country CN
Market Cap 162B CNY
Gross Margin
40%
No Stocks Found

Shanghai Runda Medical Technology Co Ltd
Glance View

Market Cap
10.4B CNY
Industry
Life Sciences Tools & Services

Shanghai Runda Medical Technology Co Ltd, nestled in the bustling heart of China's economic capital, stands as a quintessential example of a company thriving at the crossroads of innovation and healthcare. Established as a key player in medical diagnostics, Runda Medical focuses on the distribution and provision of high-quality medical devices and diagnostic solutions. Their business model revolves around integrating advanced technology with healthcare needs, enabling medical institutions to enhance their diagnostics capabilities through cutting-edge equipment and robust system support. The company holds a substantial portfolio of both proprietary and partnered products, allowing healthcare providers faster and more precise diagnostic insights. This is bolstered by a dependable supply chain and comprehensive after-sales service, ensuring that medical institutions can rely on consistent performance from their systems. Runda Medical's financial engine is powered predominantly by its distribution networks and strategic partnerships with leading medical technology firms worldwide. By leveraging these alliances, the company can offer a wide range of products that serve various segments of the medical industry, including hospitals, clinics, and laboratories. Revenue flows are primarily generated through the sale of medical devices such as automated analyzers, imaging systems, and diagnostic reagents — all designed to meet the growing demands for efficiency and accuracy in healthcare diagnosis. Moreover, their value proposition is further enhanced by the company's investments in customer education and training, ensuring that the end-users of their systems are not just purchasers but long-term partners in progress, thereby solidifying Runda Medical's reputation as a steadfast ally in China's healthcare landscape.

Intrinsic Value
28.91 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
25.9%
=
Gross Profit
2.2B
/
Revenue
8.4B
What is the Gross Margin of Shanghai Runda Medical Technology Co Ltd?

Based on Shanghai Runda Medical Technology Co Ltd's most recent financial statements, the company has Gross Margin of 25.9%.